Literature DB >> 12101174

Intranasal naloxone for life threatening opioid toxicity.

A-M Kelly, Z Koutsogiannis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12101174      PMCID: PMC1725919          DOI: 10.1136/emj.19.4.375

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


× No keyword cloud information.
  7 in total

Review 1.  Naloxone in opioid poisoning: walking the tightrope.

Authors:  S F J Clarke; P I Dargan; A L Jones
Journal:  Emerg Med J       Date:  2005-09       Impact factor: 2.740

2.  Expanding access to naloxone in the United States.

Authors:  Suzanne Doyon; Steven E Aks; Scott Schaeffer
Journal:  J Med Toxicol       Date:  2014-12

3.  Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.

Authors:  Abby M Bailey; Daniel P Wermeling
Journal:  Ann Pharmacother       Date:  2014-02-12       Impact factor: 3.154

Review 4.  Best evidence topic report. Intranasal naloxone in suspected opioid overdose.

Authors:  Helen Ashton; Ziauddin Hassan
Journal:  Emerg Med J       Date:  2006-03       Impact factor: 2.740

5.  Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial.

Authors:  Ali Mohammad Sabzghabaee; Nastaran Eizadi-Mood; Ahmad Yaraghi; Samaneh Zandifar
Journal:  Arch Med Sci       Date:  2014-05-13       Impact factor: 3.318

6.  Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies.

Authors:  B T Gufford; G R Ainslie; J R White; M E Layton; J M Padowski; G M Pollack; M F Paine
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

Review 7.  Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.

Authors:  Christa R Lewis; Hoa T Vo; Marc Fishman
Journal:  Subst Abuse Rehabil       Date:  2017-10-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.